Acute acoustic trauma (AAT) induces hearing loss through the primary hair cell death pathway called apoptosis. The hair cell death occurs by over-production of reactive oxygen species, reactive nitrogen species, and other free radicals, which result from oxidative stress destroying the antioxidant defense mechanisms in the cochlea. Pharmacological approaches have been developed to prevent or treat cochlear damage induced by AAT. The objective of this study is to investigate the therapeutic effect of the combined antioxidant drugs (4-OHPBN plus NAC) in treating hearing loss induced by AAT when these drugs are orally administered. Thirty female chinchillas (six for each group) were exposed to a 105 dB SPL octave-band noise centered at 4 kHz for 6 hours. A combination of 4-hydroxy phenyl-N-tert-butylnitrone (4-OHPBN) plus N-acetyl-L-cystein (NAC) were orally administered to all experimental groups giving a first injection 4 hour after noise exposure and continually injecting twice daily for the next two days. Cubic distortion product otoacoustic emissions (DPOAE) before noise exposure and 21 days after noise exposure were obtained and statistically analyzed. The cubic DPOAE amplitudes were significantly different among different groups at different frequencies. The oral administration of 4-OHPBN plus NAC significantly increased permanent DPOAE amplitude. The increase was partially correlated with the dose of 4-OHPBN plus NAC. These results demonstrate that the combination of 4-OHPBN plus NAC can treat acute acoustic trauma although these drugs are orally administered. At the high dose of 4-OHPBN (75 mg/kg) plus NAC (200 mg/kg), the cubic DPOAE amplitude was reduced compared to those of 4-OHPBN (50 mg/kg) plus NAC (100 mg/kg). This reduction indicates that the only highest dose of 4-OHPBN may be ototoxic.
INTRODUCTION 1)
Basically, acute acoustic trauma (AAT) leads to oxidative stress exceeding the antioxidant defense capacity in the cochlea through the over-production of reactive oxygen spe- For measuring the effectiveness of the 4-OHPBN alone and in combination with other antioxidant drugs, our previous study used IP injection. However, the most-commonly used injection method to deliver drugs in human is oral administration. Since our research goal is to develop realistic pharmacological interventions for AAT, it is necessary to use the oral administration as an injection method for evaluating the effect of injection method in investigating the effect of 4-OHPBN plus NAC on AAT. Therefore, the objectives of this study are to investigate the therapeutic effect of the combined antioxidant drugs (4-OHPBN plus NAC) in treating hearing loss induced by AAT when these drugs are orally administered. The cubic distortion product otoacoustic emissions (DPOAE) on 25 days after noise exposure were assessed in this study.
Materials and Methods

Animals and synthesis of 4-OHPBN
The experimental procedures used in this study were re- When the criterion was satisfied, the data was used for analysis. Finally, cubic DPOAE amplitudes for both ears of each animal were measured before initial noise exposure (baseline) and 21 days after noise exposure for each frequency.
Noise Exposure
Distortion Product Otoacoustic Emission
Statistical Analysis
All data are reported as mean ± standard error of mean (S.E.M). Significant differences in DPOAE amplitude among the different groups at each frequency were evaluated using 
Results
Before initial noise exposure, we confirmed that there were no significant differences in cubic DPOAE amplitudes there were no significant differences in the mean DPOAE amplitudes among different groups.
<Fig. 5> shows the cubic DPOAE amplitudes at f2=8 kHz at different groups. There were also significant differences in the mean DPOAE amplitudes among different groups. At the level of 50 dB SPL, the 3 rd experimental group (29 dB) showed significant differences in DPOAE amplitudes compared to the control group (13 dB), the 1 st experimental group (17 dB), and the 4 th experimental group (42 dB), respectively showed significant differences in DPOAE amplitudes compared to the control group (31 dB).
At the level of 70 and 75 dB SPL, there were no significant differences in the mean DPOAE amplitudes among different groups.
Discussion and Conclusions
The objective of the present study was to investigate the More various combinations of antioxidant drugs will be continually sought to maximize the effects of antioxidant drug.
The use of 4-OHPBN in combination with other antioxidant drug showed stronger effect to treat AAT. However, the maximal dosage of 4-OHPBN should be very careful because it may be ototoxic.
